Keyphrases
United States
100%
Tenofovir Disoproxil Fumarate
100%
AIDS/HIV
100%
Pre-exposure Prophylaxis (PrEP)
100%
Real-world Implementation
100%
Cost-effectiveness
15%
High Risk
15%
Clinical Trials
7%
Antiretroviral
7%
Multidrug-resistant
7%
Clinical Practice
7%
Healthy Individuals
7%
Drug Resistance
7%
Virus Strains
7%
U.S. Food
7%
Renal Disease
7%
Disease Prevention
7%
Sexually Transmitted Infections
7%
Human Immunodeficiency Virus Infection
7%
Centers for Disease Control
7%
High-risk Behavior
7%
Seroconversion
7%
Real-world Use
7%
Bone Mineral Density Loss
7%
Prevention Guidelines
7%
Patient Adherence
7%
Pharmacist Role
7%
Patient Retention
7%
Virus Acquisition
7%
Unintended Pregnancy
7%
Medication Adverse Effects
7%
Risk Compensation
7%
Retention in Care
7%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Tenofovir Disoproxil
100%
Emtricitabine
100%
Clinical Trial
20%
Human Immunodeficiency Virus Infection
20%
Virus Strain
20%
Drug Resistance
20%
Diseases
20%